Medical Devices
2004 FDA Workshop on Pre-Clinical Testing for Endovascular Grafts - July 28 - 29, 2004
Thanks to all who attended and participated in the 2004 Workshop on Pre-Clinical Testing for Endovascular Grafts. Please refer to the Workshop agenda for the proceedings and outcome of the meeting.
- Physician Survey
- Conference Overview
- Venue and Location
- Participation
- Attire
- Sponsors
- Additional Information
- Workshop Objectives
Conference Overview
We are pleased to announce the second FDA Workshop on Preclinical Testing for Endovascular Grafts.
| Dates: | July 28 - 29, 2004 |
| Location: | Hilton Washington, DC North in Gaithersburg, MD |
|
FDA Steering Committee: Dorothy B. Abel |
Scientific Advisory Committee: Mark M. Dehdashtian |
As with the previous meeting, representatives from various areas involved with the development, testing and use of endovascular grafts have been invited. There will be four sessions during the workshop:
- Animal studies;
- Fixation effectiveness and sealing;
- Implant integrity; and
- Past, present and future issues in pre-clinical testing.
Each session will begin with short presentations followed by discussion from the participants and audience.
Venue and Location
The 2004 FDA Workshop on Preclinical Testing for Endovascular Grafts will be held at the Hilton Washington, DC North, located at 620 Perry Parkway in Gaithersburg, MD. For more information and for reservations please call: 301-977-8900 or visit the Hilton Hotels web site at www.hilton.com.
Participation
Participation in the Workshop will consist of both invited participants and audience members. The invited participants include representatives from various areas involved with the development of endovascular grafts such as industry, the medical community and testing facilities. Invited participants will complete a work assignment in advance of the meeting in order to optimize the time spent during the workshop. There will be a limit of two participants per organization at each of the four sessions with a total of eight participants per organization. Audience participation is open to all who are interested in the pre-clinical testing of endovascular grafts and will be scheduled throughout the sessions.
Attire
The attire for both days will be business casual.
Sponsors
The Workshop is sponsored by the Food and Drug Administration and the Center for Devices and Radiological Health.
Additional Information
Angela Smith
angela.smith@fda.hhs.gov
301-443-8517, extension 109
Workshop Objectives
Workshop Agenda


